Michael Schaeffer has been Vivoryon’s Chief Business Officer since October 2018. He has around 20 years of experience across pharma and biotech in strategic business development, scientific project and alliance management.
Michael Schaeffer is a highly experienced serial entrepreneur and was founder, CEO and Managing Director of the biotech companies CRELUX GmbH and SiREEN AG prior to joining Vivoryon. CRELUX is a world leader in biophysical and structure-based drug discovery services.He was responsible for integrating CRELUX into WuXiAppTec, a leading Shanghai based CRO with over 20,000 employees globally, following the acquisition of CRELUX by WuXiAppTec in 2016.
Michael Schaeffer received his PhD in Molecular Biology from the Ludwig Maximilians University in Munich, Germany.